Internal Deadline: Friday, June 10, 2022, 5pm PT
External Deadline: August 1, 2022
Award Type: Grant (project support & PI salary)
Estimated Number of Awards:
Anticipated Award Amount: $325,000/year
Who May Serve as PI: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Process for Limited Submissions
PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://orif.usc.edu/oor-portal/.
Materials to submit include:
- (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
- (2) CV – (5 pages maximum)
Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
Pathway to Stop Diabetes has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes, is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management and cures. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes.
This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease – and the pathway to this impact is clear. Our vision is to create a pathway to launch the next generation of trailblazers in diabetes research.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.